e-learning
resources
Vienna 2003
Tuesday 30.09.2003
Severe pulmonary infection and sepsis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Cardiovascular effects of high dose N-acetylcysteine in severe pneumonia-induced sepsis
H. Spapen, D. N. Nguyen, J. Troubleyn, B. Scott, L. Huyghens (Brussels, Belgium)
Source:
Annual Congress 2003 - Severe pulmonary infection and sepsis
Session:
Severe pulmonary infection and sepsis
Session type:
Thematic Poster Session
Number:
2871
Disease area:
Pulmonary vascular diseases, Respiratory critical care
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
H. Spapen, D. N. Nguyen, J. Troubleyn, B. Scott, L. Huyghens (Brussels, Belgium). Cardiovascular effects of high dose N-acetylcysteine in severe pneumonia-induced sepsis. Eur Respir J 2003; 22: Suppl. 45, 2871
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Related content which might interest you:
The effect of mercaptoethylguanidine on acute lung injury associated with sepsis
Source: Eur Respir J 2003; 22: Suppl. 45, 451s
Year: 2003
N-acetylcysteine and dexamethasone in the prevention of respiratory complications in acute pancreatitis
Source: Eur Respir J 2007; 30: Suppl. 51, 51s
Year: 2007
Salmeterol prevents pneumonia and reduces biomarkers of inflammation/epithelial damage but not acute lung injury following oesophagectomy-the results of BALTI-prevention trial
Source: Annual Congress 2013 –Acute lung injury: novel clinical and experimental insights
Year: 2013
Impact of macrolide therapy on mortality in severe sepsis caused by pneumonia
Source: Eur Respir J 2009; 33: 521
Year: 2009
Efficacy of surfactant-BL in treatment ARDS in patients with severe inhalation injury
Source: Eur Respir J 2006; 28: Suppl. 50, 345s
Year: 2006
The effect of roflumilast on lipopolysaccharide-induced acute lung injury during neutropenia recovery in mice
Source: Virtual Congress 2021 – Developments in biomarkers and treatment strategies for chronic lung diseases
Year: 2021
Effects of high dose N-acetylcysteine in COPD patients
Source: Annual Congress 2012 - Trials in COPD: novel treatments and insights
Year: 2012
Effect of 2-Year therapy with Roflumilast in severe systemic inflammation in COPD with metabolic syndrome
Source: International Congress 2019 – Advances in COPD pharmacology
Year: 2019
Therapeutic effect of hypothermia on endotoxin-induced acute lung injury in rats
Source: Eur Respir J 2004; 24: Suppl. 48, 265s
Year: 2004
Risk of myocardial infarction and cardiovascular death associated with inhaled corticosteroids in COPD
Source: Eur Respir J 2010; 35: 1003-1021
Year: 2010
The effect of long-term treatment with erdosteine on moderate or severe COPD patients
Source: Eur Respir J 2005; 26: Suppl. 49, 292s
Year: 2005
Early administrations of dexamethasone, n-acetylcysteine and aprotinin have beneficial effects on inflammatory and oxidant-antioxidant status after lung contusion in rats
Source: Annual Congress 2008 - Inflammatory trigger mechanisms in asthma and COPD
Year: 2008
Dose dependent increased mortality risk in COPD patients treated with oral glucocorticoids
Source: Eur Respir J 2001; 17: 337-342
Year: 2001
Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: A randomized clinical trial
Source: International Congress 2015 – Acute critical care: news from the ICU
Year: 2015
Cardiovascular safety of high doses of the nebulized bronchodilators in acute severe asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 541s
Year: 2004
Effect of erdosteine in moderately severe COPD patients
Source: International Congress 2018 – Pharmacological management of COPD
Year: 2018
Creatine supplementation attenuates systemic and pulmonary effects of acute lung injury induced by pulmonary ischemia-reperfusion in rats
Source: Annual Congress 2012 - Lung transplantation: studies in candidates and recipients
Year: 2012
Comparison of reducing effect on lung injury of dexamethasone and bosentan in acute lung injury: An experimental study
Source: International Congress 2014 – Experimental models in acute lung injury
Year: 2014
Aspirin reduces acute lung injury in rats subjected to severe hemorrhage
Source: Eur Respir J 2004; 24: Suppl. 48, 265s
Year: 2004
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept